Andere Sprachen KALA BIO, Inc.

Aktien

A3DWPS

US4831192020

KALA

Realtime-Estimate Cboe BZX Andere Börsenplätze 15:42:32 26.06.2024			% 5 Tage	% 1. Jan.
4,755 ^USD	+1,60 %		-13,33 %	-33,14 %

17.05.	KALA BIO, INC. : HC Wainwright bekräftigt seine Kaufempfehlung	ZM
14.05.	KALA BIO, Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

KALA BIO : Corporate Overview - June 2024	05.06.
KALA BIO to Present at Jefferies Global Healthcare Conference	29.05.
KALA BIO, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14.05.
KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update	14.05.
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	01.04.
KALA BIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29.03.
KALA BIO, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29.03.
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	29.03.
KALA BIO, Inc. announced that it expects to receive $8.599799 million in funding from Baker Bros. Advisors LP	25.03.
North American Morning Briefing : Stocks Struggle After New Records	22.03.
North American Morning Briefing : Inflation -2-	15.03.
KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference	26.02.
KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference	06.02.
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	19.01.
KALA BIO, Inc. announced that it expects to receive $1.999824 million in funding	21.12.
KALA BIO, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13.11.
KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update	13.11.
KALA BIO Reports Inducement Grants under Nasdaq Listing Rule 5635(4)	21.09.23
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	20.09.23
KALA BIO to Present at H.C. Wainwright 25th Annual Global Investment Conference	05.09.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen KALA BIO, Inc.

Aktien

A3DWPS

US4831192020

KALA

Andere Sprachen

Filter